David F Horrobin
Affiliation: Laxdale Ltd
Horrobin D. Are large clinical trials in rapidly lethal diseases usually unethical?. Lancet. 2003;361:695-7 pubmed
Horrobin D. A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levels. Med Hypotheses. 2003;60:615-23 pubmed
..The mechanisms of action of these various agents are discussed, and specific suggestions are made for low toxicity maintenance therapy of mantle cell lymphoma and of other tumours which overexpress cyclin D1. ..